Additive Manufacturing: 3D-Printed Pills
Aprecia uses 3D printing to create dissolvable pills for epilepsy, which the page says can improve patient compliance and enable precise, high-dose medications.
aprecia.comCrawled Oct 16, 2026
Aprecia uses 3D printing to create dissolvable pills for epilepsy, which the page says can improve patient compliance and enable precise, high-dose medications.
Aprecia's 3DP platforms provide rapid, flexible, individualized oral drug delivery solutions for biotech companies. The page discusses additive manufacturing in tablet production.
The European Medicines Agency released its first formal Questions & Answers guidance on 3D printing for solid oral dosage forms. The page explains the guidance.
Aprecia's content covers 3DP and its applications.
The page discusses Aprecia's move of its manufacturing operations to Blue Ash, OH, and its impact on the pharmaceutical industry.
Battelle and Aprecia received a DARPA agreement to demonstrate agile pharmaceutical manufacturing using a customized chemical synthesis platform and Aprecia's 3D printing technology.
Purdue University and US Pharmacopeia host a webinar series on pharmaceutical 3D printing.
The page introduces Aprecia's leadership team and describes its members as experts in pharmaceutical printing and drug development.
Aprecia, founded in 2003, is a pharmaceutical technology company committed to achieving a new standard in modern pharmaceutics.
Aprecia provides a contact point for general questions and business opportunity inquiries.
Aprecia provides 3DP-enabled formulation platforms that the page says can help patients live healthier lives.
Aprecia's privacy policy covers personal information and online security.
Aprecia says website users agree to the Terms of Use in effect when they use the site.